SMITH & NEPHEW PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,004 GBX | +0.30% |
|
+0.77% | -6.86% |
| 05-09 | Smith & Nephew plc Announces Final Dividend of the Year Ended 31 December 2023, Payable on May 22, 2024 | CI |
| 05-09 | SMITH & NEPHEW : Q1 24: A few positives underneath the top-line miss |  |
| Sales 2024 * | 5.82B 465B | Sales 2025 * | 6.12B 489B | Capitalization | 10.96B 875B |
|---|---|---|---|---|---|
| Net income 2024 * | 541M 43.21B | Net income 2025 * | 694M 55.43B | EV / Sales 2024 * | 2.32 x |
| Net Debt 2024 * | 2.56B 204B | Net Debt 2025 * | 2.23B 178B | EV / Sales 2025 * | 2.16 x |
| P/E ratio 2024 * |
21.3
x | P/E ratio 2025 * |
16.3
x | Employees | 18,452 |
| Yield 2024 * |
3.04% | Yield 2025 * |
3.41% | Free-Float | 99.15% |
More Fundamentals
* Assessed data
More news
Latest transcript on Smith & Nephew Plc
More recommendations
More press releases
More news
| 1 day | +0.30% | ||
| 1 week | +0.77% | ||
| Current month | +2.60% | ||
| 1 month | +3.43% | ||
| 3 months | -8.05% | ||
| 6 months | +1.57% | ||
| Current year | -6.86% |
1 week
981.20
1 010.50
1 month
946.001 020.00
Current year
946.001 181.50
1 year
887.001 315.00
3 years
887.001 601.50
5 years
887.002 023.00
10 years
881.002 023.00
| Managers | Title | Age | Since |
|---|---|---|---|
Deepak Nath
CEO | Chief Executive Officer | - | 31/03/22 |
John Rogers
DFI | Director of Finance/CFO | 56 | 11-30 |
Alison Parkes
CMP | Compliance Officer | - | 31/03/99 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Marc E. Owen
BRD | Director/Board Member | 65 | 30/09/17 |
Jeremy Maiden
BRD | Director/Board Member | 62 | 13/09/23 |
Rupert Soames
CHM | Chairman | 63 | 25/04/23 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.16% | 0 M€ | -4.02% | ||
| 0.52% | 11 M€ | +0.83% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/05/24 | 1,004 | +0.30% | 1,966,596 |
| 09/05/24 | 1,002 | -0.60% | 1,764,796 |
| 08/05/24 | 1,007 | +0.97% | 3,198,860 |
| 07/05/24 | 997.8 | +0.10% | 5,800,568 |
| 03/05/24 | 996.8 | +1.14% | 2,555,394 |
Delayed Quote London S.E., May 10, 2024 at 04:35 pm
More quotes
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Calendar
24/07/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.57
USD
Average target price
16.35
USD
Spread / Average Target
+30.03%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -6.86% | 10.96B | |
| +10.39% | 126B | |
| +2.52% | 8.97B | |
| +38.96% | 5.56B | |
| -17.50% | 4.99B | |
| +8.36% | 3.44B | |
| -8.84% | 2.8B | |
| -7.52% | 2.18B | |
| -3.00% | 2.16B | |
| -21.88% | 1.82B |
- Stock Market
- Equities
- SN. Stock
